On 9th May 2018 during the 7th HTAsiaLink conference in Chiang Mai, Thailand, editors of 5 translations of the book ‘Testing Treatments: better research for better healthcare’ gave a short talk in the promotional session for the book in each language. Testing Treatment: better r

Australia developed the Life-Saving Drugs Program (LSDP) in 1995 to complement the Pharmaceutical Benefits Scheme (PBS), expanding access to high-cost drugs for rare diseases (DRD). This program, funded and administered by the Department of Health and Aged Care, permitted sponsors (often pharmaceuti

We want to hear from you! Based on the description of the Lancet Commission below, please share your inputs on the key issues, challenges or opportunities that should be considered. CLICK HERE TO JOIN OUR SURVEY or scan the QR code in the following image.----------Epidemiological modelling is an important tool to help public health planners under

Epidemiological modelling is an important tool to help public health planners understand potential disease outcomes in the population. The recent visibility of models and their perceived influence in the decision-making processes surrounding the response to the COVID-19 pandemic has led to a great d

This intervention was approved by the National Committee on AIDS Prevention and Alleviation for use in the country in 2007, The research findings will be helpful in informing the development of program’s strategies. Although appropriate policy guidance concerning the implementation of particular health technologies is context-specific, the Thai p

Abstract Background Policymakers in high-, low-, and middle-income countries alike face challenging choices about resource allocation in health. Economic evaluation can be useful in providing decision makers with the best evidence of the anticipated benefits of new investments, as well as their

Background Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include li

Abstract BACKGROUND: Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) th

According to World Health Organization (WHO) health system framework an efficient health system results in equitable access to essential health technologies with assured quality, safety, efficacy, and cost-effectiveness. National policies, essential health technology list, and evidenced-based selection of health technologies using health technology

The recent Indonesia visit is an illustration of iDSI’s ongoing commitment to building capacity in developing countries. HITAP visits help national bodies learn how to conduct Health Technology Assessments, strengthening decision-making processes and enabling gains in the quantity and quality of hea